From the Associated Press
(AP) – A new scientific statement from the American Heart Association (AHA) proposes to the Federal Drug Control Agency (DEA) to eliminate category I cannabis so that it can be widely studied by scientists.
Marijuana use has increased in the last decade, especially among people aged 18-25. A total of 47 states, the District of Columbia and 4 of the 5 US territories allow some form of cannabis use. Although many states have legalized medical and / or recreational use, the cultivation, sale, and use of cannabis is illegal at the federal level, further complicating research.
“We urgently need carefully designed, forward-looking short-term and long-term research on cannabis use and cardiovascular safety as it becomes more accessible and widely used,” said Robert L. Page II, chairman of the statement writing group. . “Society needs fact-based scientific information about the effects of cannabis on the heart and blood vessels. Funding for federal and state research needs to be increased to respond to the growing use of cannabis – to clarify the potential therapeutic properties and to help us better understand the effects of frequent cannabis use on the heart. vascular and public health. “
Although cannabis may be useful in conditions such as muscle stiffness associated with multiple sclerosis, the AHA claims that cannabis does not appear to have any well-documented benefits in preventing or treating cardiovascular disease.
Non-intoxication studies of CBD have found associations with a reduced heart rate, lower blood pressure, an increased ability of the arteries to open, and potentially reduced inflammation. Inflammation is associated with atherosclerosis, the slow narrowing of the arteries.
The way cannabis is consumed can affect how it affects the heart and blood vessels.
Cannabis, which is legal for medical purposes, must be brought into line with patient safety and efficacy, according to the AHA, which calls on the federal government to establish and require standardized labeling of THC and CBD levels for all legalized products.
Arizona’s list of qualifying conditions for medical marijuana does not currently include cardiovascular health issues.